Stryker (NYSE:SYK – Get Free Report) and Glucose Health (OTCMKTS:GLUC – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, dividends and risk.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Stryker and Glucose Health, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Stryker | 0 | 6 | 16 | 0 | 2.73 |
| Glucose Health | 0 | 0 | 0 | 0 | 0.00 |
Stryker currently has a consensus price target of $395.33, indicating a potential upside of 24.94%. Given Stryker’s stronger consensus rating and higher probable upside, research analysts clearly believe Stryker is more favorable than Glucose Health.
Risk and Volatility
Valuation and Earnings
This table compares Stryker and Glucose Health”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Stryker | $25.12 billion | 4.83 | $3.25 billion | $8.64 | 36.62 |
| Glucose Health | $340,000.00 | 37.74 | -$230,000.00 | ($0.03) | -15.91 |
Stryker has higher revenue and earnings than Glucose Health. Glucose Health is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Stryker and Glucose Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Stryker | 13.20% | 23.42% | 11.04% |
| Glucose Health | -84.68% | N/A | N/A |
Insider & Institutional Ownership
77.1% of Stryker shares are held by institutional investors. 4.6% of Stryker shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
Stryker beats Glucose Health on 12 of the 14 factors compared between the two stocks.
About Stryker
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
About Glucose Health
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.
